Infliximab vs placebo
At least 50% decrease in HS Severity Index · participants with hidradenitis suppurativa
Infliximab showed no clear difference in at least 50% decrease in HS Severity Index compared with placebo (moderate certainty).
1 finding from 1 review
- RR 4.8 [0.6, 38.48]1 study · 33 participantsModerate